Governance Celyad Oncology SA

CYAD

BE0974260896

Biotechnology & Medical Research

Real-time Euronext Bruxelles Other stock markets 05:57:38 2026-01-13 am EST			5-day change	1st Jan Change
0.1740 ^EUR	-6.20%		-7.69%	+2.35%

25-09-30	Celyad Oncology to Sell Belgian Research Facility for EUR3 Million	MT
25-09-29	Celyad Oncology announces research facility divestiture	RE

Executive Committee: Celyad Oncology SA

Manager

Positions heldSince

Matthew Kane

49 year

Chief Executive Officer

2024-09-30

David Georges

Chief Administrative Officer	2022-06-22
Director of Finance/CFO	2018-12-31

An Phan

51 year

General Counsel

2021-08-31

Composition of the Board of Directors: Celyad Oncology SA

Director

CommitteesSince

Hilde Windels

61 year

Audit Committee	2023-06-22
Compensation Committee Chair	2022-06-22
Nominating Committee Chair	2022-06-22
Compensation Committee	2023-06-22
Nominating Committee	2023-06-22

Dominic Piscitelli

52 year

Governance Committee	2020-05-05
Nominating Committee	2020-05-05
Audit Committee Chair	2020-05-05

J. Christopher LiPuma

55 year

Compensation Committee	2022-01-19
Nominating Committee	2022-01-19

Marina Udier

Audit Committee

2011-01-10

Sharon Roberg-Perez

Director/Board Member

Sage Mandel

Director/Board Member

Jonathan M. James

Director/Board Member

Ami Patel Shah

Director/Board Member

2021-12-07

Serge Goblet

Director/Board Member

2007-12-31

Michel Lussier

69 year

Director/Board Member

2022-06-22

Latest Appointments: Celyad Oncology SA

24-09-17	Celyad Oncology Names New CEO to Start in October	MT
24-09-16	Celyad Oncology Appoints Matt Kane as Chief Executive Officer, Effective October 1, 2024	CI
23-12-05	Celyad Oncology CEO Resigns	MT
23-12-04	Celyad Oncology CEO Steps Down for Personal Reasons	MT
23-12-04	Celyad Oncology SA Announces Executive Change	CI
23-12-04	Celyad Oncology Sa Announces Executive Change	CI
23-03-24	Celyad Oncology SA Appoints Georges Rawadi as its New Chief Executive Officer	CI

More news

Former Officers and Directors: Celyad Oncology SA

Insider

Positions held

SinceUntil

Philippe Nobels

Human Resources Officer

2016-09-30

2023-01-31

Charles Morris

Chief Tech/Sci/R&D Officer

2021-04-18

2022-12-31

Sara Zelkovic

Investor Relations Contact	-	2022-11-30
Public Communications Contact	-	2022-11-30

Philippe Dechamps

General Counsel

2016-08-31

2022-07-28

David Gilham

Chief Tech/Sci/R&D Officer

2016-08-31

2022-06-23

Filippo Petti

Director/Board Member	2019-11-28	2022-06-22
Chief Executive Officer	2019-03-31	2022-06-22
Director of Finance/CFO	2018-09-02	2022-06-22

Stephen Rubino

Corporate Officer/Principal

2020-01-31

2022-03-31

Frederic Lehmann

Chief Tech/Sci/R&D Officer	2016-06-30	2022-03-31
Corporate Officer/Principal	2015-09-13	-

Peggy Sotiropoulou

Chief Tech/Sci/R&D Officer

2017-09-30

2021-06-30

Elena Spanjaard

General Counsel

2018-07-31

2021-03-31

Margo Roberts

Director/Board Member	2018-07-31	2020-08-05
Independent Dir/Board Member	2018-07-31	2020-08-05

Maria Koehler

Director/Board Member	2020-03-23	-
Independent Dir/Board Member	2020-03-23	-

Christian Homsy

Director/Board Member	2007-07-23	2019-11-28
Chief Executive Officer	2007-07-23	2019-03-31
Founder	2007-07-23	2019-11-28

Anne Moore

Corporate Officer/Principal

2019-03-07

2019-10-31

Patrick Jeanmart

Director of Finance/CFO	2007-08-31	2018-09-02
Investor Relations Contact	2007-08-31	2018-09-02
Corporate Officer/Principal	2018-09-02	2018-11-30

Carri Duncan

Public Communications Contact

2018-09-30

Georges Rawadi

Corporate Officer/Principal	2014-05-31	2018-03-22
Director/Board Member	2023-04-26	2023-11-30
Chief Executive Officer	2023-04-26	2023-11-30

Chris de Jonghe

Director/Board Member	2012-12-31	2017-05-04
Independent Dir/Board Member	2015-06-01	2017-05-04

Dieter Hauwaerts

Chief Operating Officer	2015-10-31	-
Corporate Officer/Principal	2015-10-31	2017-04-30

Peter de Waele

Chief Tech/Sci/R&D Officer	2010-10-31	-
Corporate Officer/Principal	2010-10-31	-

Steve Buckanavage

Sales & Marketing

2016-11-30

William Wijns

Director/Board Member	2016-02-07	2016-03-31
Founder	2007-07-23	2016-03-31
Independent Dir/Board Member	2015-06-01	2016-02-07

Richard Mountfield

General Counsel

2016-02-02

Pierre Brynaert

Human Resources Officer

2016-01-03

Jean-Marc Heynderickx

Director/Board Member	2013-01-30	2015-08-20
Independent Dir/Board Member	2013-01-30	2015-08-20

Debasish Francois Roychowdhury

Director/Board Member	2015-08-20	-
Independent Dir/Board Member	2015-08-20	-

Eytan Breman

Chief Tech/Sci/R&D Officer

2022-05-31

Warren Sherman

Chief Tech/Sci/R&D Officer

2014-10-31

Hanspeter Spek

Director/Board Member	2014-05-04	-
Independent Dir/Board Member	2014-05-04	-

Danny F. Wong

Director/Board Member

2013-12-31

Gaëtane Metz

Chief Operating Officer

2013-10-06

Jaak Minten

Corporate Officer/Principal

2012-12-31

Alexander M. Milstein

Corporate Officer/Principal

2013-05-13

Chris Heymans

Corporate Officer/Principal

2011-10-12

Francis Verhoeye

Corporate Officer/Principal

2011-10-12

Anne Portzenheim

Public Communications Contact

2011-10-12

Gisèle Deblandre

Corporate Officer/Principal

2010-05-25

Philippe Ronse

Corporate Officer/Principal

2008-02-29

Jean-Pierre Latere

Chief Operating Officer

2016-12-31

Chris Buyse

Director/Board Member	2007-12-31	-
Independent Dir/Board Member	2007-12-31	-

Roland Gordon-Beresford

General Counsel

2007-12-31

Sophie Henry

Chief Tech/Sci/R&D Officer	2007-11-30	-
General Counsel	2007-11-30	-

Rudy Dekeyser

Director/Board Member	2013-12-31	-
Independent Dir/Board Member	2013-12-31	-

Ik-Hwan Lee

Chief Tech/Sci/R&D Officer	-	-
Founder	-	-

Peter Wilhelm

Director/Board Member

2010-05-25

Jean Sequaris

Director/Board Member

Vinciane Gaussin

Chief Tech/Sci/R&D Officer

Tse Wai Wu

Director/Board Member

Louise Proulx

Director/Board Member	-	-
Independent Dir/Board Member	-	-

Vincent Brichard

Corporate Officer/Principal

Jan Peter Andersson

Director/Board Member	-	-
Independent Dir/Board Member	-	-

Age distribution of managers

Parity Men Women

Male	9
Female	4

Of which Executive Committee

Male	2
Female	1

Of which Directors

Male	7
Female	3

Celyad Oncology SA is a biotechnology company focused on the discovery and development of innovative technologies chimeric antigen receptor (CAR) T-cell therapies. The company is focusing on opportunities to fully harness the true potential of its proprietary technology platforms and intellectual property and support the development of next-generation CAR T candidates in solid tumors and hematological malignancies.

Employees

Sector

Biotechnology & Medical Research

Calendar

Mar. 18 - Q4 2025 Earnings Release (Projected)

More about the company